Literature DB >> 10790647

Alternatives to Autogenous Bone Graft: Efficacy and Indications.

.   

Abstract

Bone grafting is frequently used to augment bone healing with the numerous approaches to reconstructing or replacing skeletal defects. Autologous cancellous bone graft remains the most effective grafting material because it provides the three elements required for bone regeneration: osteoconduction, osteoinduction, and osteogenic cells. Autologous cortical bone graft provides these three components to a limited extent as well and also provides the structural integrity important in reconstruction of larger defects. However, because autogenous grafting is associated with several shortcomings and complications, including limited quantities of bone for harvest and donor-site morbidity, alternatives have been used in a wide range of orthopaedic pathologic conditions. Grafting substitutes currently available include cancellous and cortical allograft bone, ceramics, demineralized bone matrix, bone marrow, and composite grafts. No single alternative graft material provides all three components for bone regeneration. The clinical applications for each type of material are dictated by its particular structural and biochemical properties. Composite grafts consisting of several materials are often used to maximize bone healing, especially where the grafting site is compromised.

Entities:  

Year:  1995        PMID: 10790647     DOI: 10.5435/00124635-199501000-00001

Source DB:  PubMed          Journal:  J Am Acad Orthop Surg        ISSN: 1067-151X            Impact factor:   3.020


  92 in total

1.  Bone tissue engineering in a rotating bioreactor using a microcarrier matrix system.

Authors:  E A Botchwey; S R Pollack; E M Levine; C T Laurencin
Journal:  J Biomed Mater Res       Date:  2001-05

2.  Mesenchymal stem cells combined with biphasic calcium phosphate ceramics promote bone regeneration.

Authors:  T L Livingston; S Gordon; M Archambault; S Kadiyala; K McIntosh; A Smith; S J Peter
Journal:  J Mater Sci Mater Med       Date:  2003-03       Impact factor: 3.896

3.  Spinal fusion using an autologous growth factor gel and a porous resorbable ceramic.

Authors:  William R Walsh; Andreas Loefler; Sean Nicklin; Doug Arm; Ralph E Stanford; Yan Yu; Richard Harris; R M Gillies
Journal:  Eur Spine J       Date:  2004-03-18       Impact factor: 3.134

4.  Optimally porous and biomechanically compatible scaffolds for large-area bone regeneration.

Authors:  Ami R Amini; Douglas J Adams; Cato T Laurencin; Syam P Nukavarapu
Journal:  Tissue Eng Part A       Date:  2012-04-16       Impact factor: 3.845

5.  Effects of a perfusion bioreactor activated novel bone substitute in spine fusion in sheep.

Authors:  Jesper Roed Sørensen; Kariatta Ester Koroma; Ming Ding; David Wendt; Stig Jespersen; Maria Vinther Juhl; Naseem Theilgaard; Ivan Martin; Søren Overgaard
Journal:  Eur Spine J       Date:  2012-07-10       Impact factor: 3.134

6.  Reconstruction of Large Diaphyseal Defects of the Femur and the Tibia with Autologous Bone.

Authors:  Charles E Dumont; Ulrich G Exner
Journal:  Eur J Trauma Emerg Surg       Date:  2009-01-19       Impact factor: 3.693

7.  [Conductive bone substitute material with variable antibiotic delivery].

Authors:  C Englert; P Angele; J Fierlbeck; S Dendorfer; T Schubert; R Müller; S Lienhard; J Zellner; M Nerlich; C Neumann
Journal:  Unfallchirurg       Date:  2007-05       Impact factor: 1.000

8.  A radiographic and clinical comparison of reamer-irrigator-aspirator versus iliac crest bone graft in ankle arthrodesis.

Authors:  Scott R Nodzo; Nathan B Kaplan; Donald W Hohman; Christopher A Ritter
Journal:  Int Orthop       Date:  2014-04-29       Impact factor: 3.075

Review 9.  Tissue engineered bone grafts: biological requirements, tissue culture and clinical relevance.

Authors:  Mirjam Fröhlich; Warren L Grayson; Leo Q Wan; Darja Marolt; Matej Drobnic; Gordana Vunjak-Novakovic
Journal:  Curr Stem Cell Res Ther       Date:  2008-12       Impact factor: 3.828

10.  Calcium sulfate as bone graft substitute in the treatment of osseous bone defects, a prospective study.

Authors:  Yashavantha Kumar C; Nalini K B; Jagdish Menon; Dilip Kumar Patro; Banerji B H
Journal:  J Clin Diagn Res       Date:  2013-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.